References

Kidney Function Restoration Program

Natural Treatments to get rid of Kidney Problems

Get Instant Access

1. Lazarou, J., Pomeranz, B. H., Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies, JAMA, 279(15), 1200, 1998.

2. Pirmohamed, M., Breckenridge, A. M., Kitteringham, N. R., Park, B. K. Adverse drug reactions, BMJ, 316(7140), 1295, 1998.

3. Miller, E. C., Miller, J. A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules, Pharmacol Rev, 18, 805, 1966.

4. Weisburger, J. H., Weisburger, E. K. Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids, Pharmacol Rev, 25(1), 1, 1973.

5. Lefrak, E. A., Pitha, J., Rosenheim, S., Gottlieb, J. A. Aclinicopathologic analysis of adriamycin cardiotoxicity, Cancer, 32(2), 302, 1973.

6. Loehrer, P. J., Einhorn, L. H. Drugs five years later. Cisplatin, Ann Intern Med, 100(5), 704, 1984.

7. Singal, P. K., Iliskovic, N. Doxorubicin-induced cardiomyopathy, N Engl J Med, 339(13), 900, 1998.

8. Weinberg, J. M. The cellular basis of nephrotoxicity. In: Schrier RW, Gottschalk CW, editors. Diseases of the Kidney. Boston: Little Brown, 1031, 1993.

9. Arany, I., Safirstein, R. L. Cisplatin nephrotoxicity, Semin Nephrol, 23(5), 460, 2003.

10. Kawai, Y., Kohda, Y., Kodawara, T., Gemba, M. Protective effect of a protein kinase inhibitor on cellular injury induced by cephaloridine in the porcine kidney cell line LLC-PK(1), J Toxicol Sci, 30(3), 157, 2005.

11. Smith, C. R., Lipsky, J. J., Laskin, O. L., Hellmann, D. B., Mellits, E. D., Long-streth, J., Lietman, P. S. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin, N Engl J Med, 302(20), 1106, 1980.

12. Barza, M., Ioannidis, J. P., Cappelleri, J. C., Lau, J. Single or multiple daily doses of aminoglycosides: a meta-analysis, BMJ, 312(7027), 338, 1996.

13. Perazella, M. A., Eras, J. Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis, 35(5), 937, 2000.

14. Barrett, B. J. Contrast nephrotoxicity, J Am Soc Nephrol, 5(2), 125, 1994.

15. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephro-pathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia), Lancet, 349(9069), 1857, 1997.

16. Madias, N. E., Harrington, J. T. Platinum nephrotoxicity, Am J Med, 65(2), 307,1978.

17. Heidemann, H. T., Muller, S., Mertins, L., Stepan, G., Hoffmann, K., Ohnhaus, E. E. Effect of aminophylline on cisplatin nephrotoxicity in the rat, Br J Pharmacol, 97(2), 313, 1989.

18. Lebwohl, D., Canetta, R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update, Eur J Cancer, 34(10), 1522, 1998.

19. Boton, R., Gaviria, M., Batlle, D. C. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy, Am J Kidney Dis, 10(5), 329, 1987.

20. Andoh, T. F., Burdmann, E. A., Bennett, W. M. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations, Semin Nephrol, 17(1), 34, 1997.

21. Pham, P. T., Peng, A., Wilkinson, A. H., Gritsch, H. A., Lassman, C., Pham, P. C., Danovitch, G. M. Cyclosporine and tacrolimus-associated thrombotic microan-giopathy, Am J Kidney Dis, 36(4), 844, 2000.

22. Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., Zidek, W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine, N Engl J Med, 343(3), 180, 2000.

23. Nzerue, C. M., Hewan-Lowe, K., Riley, L. J., Jr. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives, Am J Kidney Dis, 35(5), 783, 2000.

24. Kadiri, S., Arije, A., Salako, B. L. Traditional herbal preparations and acute renal failure in south west Nigeria, Trop Doct, 29(4), 244, 1999.

25. Solomon, R., Werner, C., Mann, D., D'Elia, J., Silva, P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents, N Engl J Med, 331(21), 1416, 1994.

26. Cosentino, F. Drugs for the prevention and treatment of acute renal failure, Cleve Clin J Med, 62(4), 248, 1995.

27. Taguchi, T., Nazneen, A., Abid, M. R., Razzaque, M. S. Cisplatin-associated nephrotoxicity and pathological events, Contrib Nephrol, 148, 107, 2005.

28. Royer, B., Guardiola, E., Polycarpe, E., Hoizey, G., Delroeux, D., Combe, M., Chaigneau, L., Samain, E., Chauffert, B., Heyd, B., Kantelip, J. P., Pivot, X. Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding, Anticancer Drugs, 16(9), 1009, 2005.

29. Baliga, R., Ueda, N., Walker, P. D., Shah, S. V. Oxidant mechanisms in toxic acute renal failure, Drug Metab Rev, 31(4), 971, 1999.

30. Jansen, B. A., Brouwer, J., Reedijk, J. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs, J Inorg Biochem, 89(3-4), 197, 2002.

31. Ramesh, G., Reeves, W. B. Inflammatory cytokines in acute renal failure, Kidney Int Suppl, (91), S56, 2004.

32. Ramesh, G., Reeves, W. B. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice, Am J Physiol Renal Physiol, 289(1), F166, 2005.

33. Townsend, D. M., Deng, M., Zhang, L., Lapus, M. G., Hanigan, M. H. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells, J Am Soc Nephrol, 14(1), 1, 2003.

34. Uehara, T., Watanabe, H., Itoh, F., Inoue, S., Koshida, H., Nakamura, M., Yamate, J., Maruyama, T. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats, Arch Toxicol, 79(8), 451, 2005.

35. Santoso, J. T., Lucci, J. A., 3rd, Coleman, R. L., Schafer, I., Hannigan, E. V. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial, Cancer Chemother Pharmacol, 52(1), 13, 2003.

36. Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., Safirstein, R. L. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells, Am J Physiol Renal Physiol, 287(3), F543, 2004.

37. Basnakian, A. G., Apostolov, E. O., Yin, X., Napirei, M., Mannherz, H. G., Shah, S. V. Cisplatin nephrotoxicity is mediated by deoxyribonuclease I, J Am Soc Nephrol, 16(3), 697, 2005.

38. Huang, Q., Dunn, R. T., 2nd, Jayadev, S., DiSorbo, O., Pack, F. D., Farr, S. B., Stoll, R. E., Blanchard, K. T. Assessment of cisplatin-induced nephrotoxicity by microarray technology, Toxicol Sci, 63(2), 196, 2001.

39. Somani, S. M., Frank, S., Rybak, L. P. Responses of antioxidant system to acute and trained exercise in rat heart subcellular fractions, Pharmacol Biochem Behav, 51(4), 627, 1995.

40. Mohan, I. K., Khan, M., Shobha, J. C., Naidu, M. U., Prayag, A., Kuppusamy, P., Kutala, V. K. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats, Cancer Chemother Pharmacol, 58(6), 802, 2006.

41. Cetin, R., Devrim, E., Kilicoglu, B., Avci, A., Candir, O., Durak, I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods, J Appl Toxicol, 26(1), 42, 2006.

42. Conklin, K. A. Dietary antioxidants during cancer chemotherapy: impact on chemo-therapeutic effectiveness and development of side effects, Nutr Cancer, 37(1), 1, 2000.

Antunes, L. M., Araujo, M. C., Darin, J. D., Bianchi, M. L. Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells, MutatRes, 465(1-2), 131, 2000.

Davis, C. A., Nick, H. S., Agarwal, A. Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide, J Am Soc Nephrol, 12(12), 2683, 2001.

Appenroth, D., Frob, S., Kersten, L., Splinter, F. K., Winnefeld, K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats, Arch Toxicol, 71(11), 677, 1997.

Antunes, L. M., Francescato, H. D., Darin, J. D., de Lourdes, P. B. M. Effects of selenium pretreatment on cisplatin-induced chromosome aberrations in wistar rats, Teratog Carcinog Mutagen, 20(6), 341, 2000.

Ozen, S., Akyol, O., Iraz, M., Sogut, S., Ozugurlu, F., Ozyurt, H., Odaci, E., Yildirim, Z. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats, J Appl Toxicol, 24(1), 27, 2004. Hara, M., Yoshida, M., Nishijima, H., Yokosuka, M., Iigo, M., Ohtani-Kaneko, R., Shimada, A., Hasegawa, T., Akama, Y., Hirata, K. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats, J Pineal Res, 30(3), 129, 2001.

Wu, Y. J., Muldoon, L. L., Neuwelt, E. A.Thechemoprotectiveagent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway, J Pharmacol Exp Ther, 312(2), 424, 2005.

Ozyurt, H., Yildirim, Z., Kotuk, M., Yilmaz, H. R., Yagmurca, M., Iraz, M., Sogut, S., Gergerlioglu, S. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner, J Appl Toxicol, 24(4), 269, 2004.

Satoh, M., Kashihara, N., Fujimoto, S., Horike, H., Tokura, T., Namikoshi, T., Sasaki, T., Makino, H. A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo, J Pharmacol Exp Ther, 305(3), 1183, 2003.

Asna, N., Lewy, H., Ashkenazi, I. E., Deutsch, V., Peretz, H., Inbar, M., Ron, I. G. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity, Life Sci, 76(16), 1825, 2005.

Yalcin, S., Muftuoglu, S., Cetin, E., Sarer, B., Yildirim, B. A., Zeybek, D., Orhan, B. Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin, Med Oncol, 20(2), 169, 2003.

Francescato, H. D., Coimbra, T. M., Costa, R. S., Bianchi Mde, L. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis, Kidney Blood Press Res, 27(3), 148, 2004.

Kadikoylu, G., Bolaman, Z., Demir, S., Balkaya, M., Akalin, N., Enli, Y. The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys, Hum Exp Toxicol, 23(1), 29, 2004. Fujihara, C. K., Sena, C. R., Malheiros, D. M., Mattar, A. L., Zatz, R. Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury, Am J Physiol Renal Physiol, 290(3), F632, 2006.

Srivastava, R. C., Farookh, A., Ahmad, N., Misra, M., Hasan, S. K., Husain, M. M. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats, Biometals, 9(2), 139, 1996.

Saad, S. Y., Najjar, T. A., Daba, M. H., Al-Rikabi, A. C. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine, Chemotherapy, 48(6), 309, 2002.

59. Saleh, S., El-Demerdash, E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide, Basic Clin Pharmacol Toxicol, 97(2), 91, 2005.

60. Cornelison, T. L., Reed, E. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin, Gynecol Oncol, 50(2), 147, 1993.

61. Hanigan, M. H., Deng, M., Zhang, L., Taylor, P. T., Jr., Lapus, M. G. Stress response inhibits the nephrotoxicity of cisplatin, Am J Physiol Renal Physiol, 288(1), F125, 2005.

62. Zhang, J. G., Lindup, W. E. Cisplatin-induced changes in adenine nucleotides in rat kidney slices: amelioration by tiopronin and procaine, J Pharm Pharmacol, 49(11), 1136, 1997.

63. Esposito, M., Vannozzi, M. O., Viale, M., Fulco, R. A., Collecchi, P., Merlo, F., De Cian, F., Zicca, A., Cadoni, A., Poirier, M. C. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity, Carcinogenesis, 14(12), 2595, 1993.

64. Vassallo, R., Lipsky, J. J. Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice, Mayo Clin Proc, 73(4), 346, 1998

65. Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., Karaoglu, A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats, Toxicology, 212(2-3), 116, 2005.

66. Kondo, Y., Himeno, S., Satoh, M., Naganuma, A., Nishimura, T., Imura, N. Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum, Cancer Chemother Pharmacol, 53(1), 33, 2004.

67. Kohda, Y., Matsunaga, Y., Yonogi, K., Kawai, Y., Awaya, A., Gemba, M. Protective effect of serum thymic factor, FTS, on cephaloridine-induced nephrotoxicity in rats, Biol Pharm Bull, 28(11), 2087, 2005.

68. Ramesh, G., Reeves, W. B. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha, Kidney Int, 65(2), 490, 2004.

69. Al-Majed, A. A., Abd-Allah, A. R., Al-Rikabi, A. C., Al-Shabanah, O. A., Mostafa, A.M. Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats, J Biochem Mol Toxicol, 17(3), 146, 2003.

70. Conklin, K. A. Cancer chemotherapy and antioxidants, JNutr, 134(11), 3201S, 2004.

71. Ajith, T. A., Jose, N., Janardhanan, K. K. Amelioration of cisplatin induced neph-rotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus, J Exp Clin Cancer Res, 21(2), 213, 2002.

72. Annie, S., Rajagopal, P. L., Malini, S. Effect of Cassia auriculata Linn. root extract on cisplatin and gentamicin-induced renal injury, Phytomedicine, 12(8), 555, 2005.

73. Shirwaikar, A., Malini, S., Kumari, S. C. Protective effect of Pongamiapinnataflowers against cisplatin and gentamicin induced nephrotoxicity in rats, IndJ Exp Biol, 41(1), 58, 2003.

74. Shirwaikar, A., Issac, D., Malini, S. Effect of Aervalanata on cisplatin and gentamicin models of acute renal failure, J Ethnopharmacol, 90(1), 81, 2004.

75. Shirwaikar, A., Setty, M., Bommu, P. Effect of lupeol isolated from Crataeva nurvala Buch.-Ham. stem bark extract against free radical induced nephrotoxicity in rats, IndJ Exp Biol, 42(7), 686, 2004.

76. Kim, S. H., Hong, K. O., Hwang, J. K., Park, K. K. Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice, Food Chem Toxicol, 43(1), 117, 2005.

Shimeda, Y., Hirotani, Y., Akimoto, Y., Shindou, K., Ijiri, Y., Nishihori, T., Tanaka, K. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats, Biol Pharm Bull, 28(9), 1635, 2005.

Naidu, M. U., Shifow, A. A., Kumar, K. V., Ratnakar, K. S. Ginkgo biloba extract ameliorates gentamicin-induced nephrotoxicity in rats, Phytomedicine, 7(3), 191, 2000.

Disel, U., Paydas, S., Dogan, A., Gulfiliz, G., Yavuz, S. Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: an experimental animal study, Transplant Proc, 36(5), 1372, 2004. Shi, S., Zheng, S., Jia, C., Zhu, Y., Xie, H. The effect of an antioxidant tea polyphenols on cell apoptosis in rat model of cyclosporine-induced chronic nephrotoxicity, Zhonghua Wai Ke Za Zhi, 40(9), 709, 2002.

Wang, C., Salahudeen, A. K. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo, Transplantation, 58(8), 940, 1994.

Parra Cid, J. R., Garcia, C., Alvarez, C., De Arriba, G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity, Toxicology, 189(1-2), 99, 2003.

Naidu, M. U., Kumar, K. V., Shifow, A. A., Prayag, A., Ratnakar, K. S. Lacidipine protects against cyclosporine-induced nephrotoxicity in rats, Nephron, 81(1), 60,

Was this article helpful?

0 0
Losing Weight Without Starving

Losing Weight Without Starving

Tired of Trying To Loose Weight And It Never Works or You Have To Starve Yourself Well Here's A Weight Loss Plan That takes Care of Your Weight Problem And You Can Still Eat. In This Book, You’ll Learn How To Lose Weight And Not Feel Hungry! In An Easy Step-By-Step Process That Enables You To Feel Good About Loosing Weight As Well As Feeling Good Because Your Stomach Is Still Full.

Get My Free Ebook


Post a comment